|
|
|
|
|
by estearum
15 days ago
|
|
Unless you're talking about trials with millions of participants, what you'll actually get is just noise. And probably a lot of death or maiming from drug interactions. Which would also make it harder to get the couple million people to start with. Edit: According to Claude you're actually talking more like several hundred million patients, i.e. more Alzheimer's patients than exist, to detect a single ingredient's effect. |
|